Trial Profile
immunogenicity and safety of Imovax Polio [poliovirus vaccine live oral] in Chinese infants compared to local OPV
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Feb 2014
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine live oral (Primary) ; Poliovirus vaccine live oral (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Sanofi; Sanofi Pasteur
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2008 Planned end date 1 Dec 2008 added as reported by ClinicalTrials.gov
- 24 Sep 2008 Primary endpoint amended as reported by ClinicalTrials.gov